Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 21.90 billion as of August 14, 2025. Its market cap has increased by 151.52% in one year.

Market Cap

21.90B

Enterprise Value

23.64B

Revenue

749.91M

Ranking

n/a

PE Ratio

n/a

Stock Price

24.80

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 21.90B, an increase of 647.59%. That is a compound annual growth rate of 15.03%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	21.90B	92.40%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	5.92B	14.66%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	417.76B
WuXi AppTec	286.17B
Shenzhen Mindray Bio-Medical Electronics	286.01B
Sichuan Biokin Pharmaceutical	125.34B
Aier Eye Hospital Group	121.03B
Zhangzhou Pientzehuang Pharmaceutical.,	121.00B
Shanghai United Imaging Healthcare	107.46B
Yunnan Baiyao Group Co.,Ltd	99.92B

Market Cap Rankings